showed that NAC administration before the chemotherapy could improve reproductive functions and the gonadal hormone disturbance in female rats through its protective effects against oxidative stress (Reference Helal30)
Ipamorelin is a growth hormone secretagogue that stimulates the release of natural growth hormone from the pituitary gland
2026), coupled with its high mortality risk and the lack of an effective antidote, alongside its potential for promoting weight loss without muscle mass loss and therapeutic uncoupling at low doses, underscores the urgent need to investigate the underlying molecular mechanisms
Yes, a licensed provider must evaluate and prescribe it
The HRS9531-203 clinical trial is a multicentre, randomised, double-blind, placebo-parallel-controlled, Phase 2 trial (NCT06054698) conducted by Hengrui Pharma in China to evaluate the efficacy and safety of the 8 mg dose of HRS9531 injection in adults (ages 18-65) with overweight or obesity (BMI 24-40 kg/m2) without type 2 diabetes
